NEWS & MEDIA
We’re not only at the front lines of therapeutic advancement, we’re also continuously making headlines in healthcare, business, and research markets.
PRESS RELEASES
BeyondSpring Strengthens Executive Rank for Pipeline Expansion and Commercialization Readiness in China
BeyondSpring Strengthens Executive Rank for Pipeline Expansion and Commercialization Readiness in China January 6, 2020 Dr. James Tonra Promoted to Chief Scientific Officer; Roland Liu Named Chief Commercial Officer for China Subsidiary NEW YORK, Jan. 06, 2020 (GLOBE...
BeyondSpring Publishes Report on Benefits and Mechanism of Plinabulin in Reducing Neutropenia with Multiple Chemotherapies
BeyondSpring Publishes Report on Benefits and Mechanism of Plinabulin in Reducing Neutropenia with Multiple Chemotherapies December 19, 2019 Plinabulin Protects Bone Marrow from Chemotherapy-Induced Deficiencies with a Differentiated Yet Complimentary Mechanism to...
BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update
BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update December 18, 2019 Preparing to Submit NDA in China for Chemotherapy-Induced Neutropenia ("CIN") in Q1 2020 / Plinabulin's Anti-Cancer and CIN Prevention Mechanism Published in Peer...
BeyondSpring to Host Third-Quarter 2019 Financial Results and Operational Update Conference Call on December 18, 2019
BeyondSpring to Host Third-Quarter 2019 Financial Results and Operational Update Conference Call on December 18, 2019 December 11,2019 NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global...
BeyondSpring’s Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for Chemotherapy-Induced Neutropenia Presented at ASH 2019 Annual Meeting
BeyondSpring's Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for Chemotherapy-Induced Neutropenia Presented at ASH 2019 Annual Meeting December 10, 2019 Trial Aims to Optimize Chemotherapy by Minimizing Dose...
MEDIA
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.